| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
Across the last three months, Oric Pharmaceuticals, Inc.'s insiders have reduced their positions by a net 111,700 shares worth roughly $1.5M. In the past 30 days, 0 insiders bought and 1 sold.
The insider who sold still holds shares after the sale.
Counted by filing, the last 12 months brought no open-market purchases and 12 sales by 4 insiders worth about $3.0M. The 12 months before that brought 1 open-market purchase by 1 insider worth about $263K and 12 sales by 3 insiders worth about $4.0M.
9 of the 12 sales in the last 12 months were made under a Rule 10b5-1 trading plan; the rest were not.
The largest open-market purchase in the last two years was 28,000 shares by Angie You (Director) at an average $9.39 on June 23, 2025, about $263K. Twelve months later ORIC was down 15%.
| Role | Insider | Shares | Value | 30d |
|---|---|---|---|---|
| CEO | 581.7K | $5.58M | - | |
| Dir | 241.8K | $2.32M | - | |
| Dir | 84.2K | $807.5K | - | |
| CFO | 69.8K | $669.7K | -14,000 | |
| Other | 68.1K | $653.5K | - |
Buys and sells only
| Date | Insider | Role | Type | Shares | Price | Value | Chg% | 3M | 12M | SEC |
|---|---|---|---|---|---|---|---|---|---|---|
| Oct 20, 2026 | Dominic Piscitelli64 | Chief Financial Officer | Sale+OE10b5-1 | 14,000 | $13.53 | $189,390.60 | -16.7% | - | - | |
| Oct 1, 2026 | Richard A. Heyman73 | Director | Sale+OE10b5-1 | 6,700 | $12.91 | $86,524.47 | -2.7% | - | - | |
| Sep 28, 2026 | Dominic Piscitelli64 | Chief Financial Officer | Sale+OE10b5-1 | 13,400 | $13.53 | $181,257.78 | -16.1% | - | - | |
| Sep 24, 2026 | Dominic Piscitelli64 | Chief Financial Officer | Sale+OE10b5-1 | 600 | $13.50 | $8,102.50 | -0.9% | - | - | |
| Aug 26, 2026 | Dominic Piscitelli64 | Chief Financial Officer | Sale+OE10b5-1 | 77,000 | $13.69 | $1,053,814.30 | -52.4% | - | - | |
| Jul 24, 2026 | Richard A. Heyman73 | Director | Sale+OE10b5-1 | 13,100 | $12.02 | $157,462.00 | -6.0% | +12.6% | - | |
| Jul 6, 2026 | Richard A. Heyman73 | Director | Sell10b5-1 | 300 | $12.00 | $3,600.00 | -0.1% | +14.5% | - | |
| Feb 24, 2026 | Dominic Piscitelli64 | Chief Financial Officer | Sale+OE10b5-1 | 52,000 | $13.51 | $702,686.40 | -43.3% | -36.5% | - | |
| Jan 16, 2026 | Richard A. Heyman73 | Director | Sell10b5-1 | 6,700 | $12.00 | $80,430.82 | -3.0% | -15.6% | - | |
| Dec 16, 2025 | Pratik S Multani | Chief Medical Officer | Sale+OE | 10,720 | $9.06 | $97,128.56 | -13.6% | +34.0% | - |